A population-based longitudinal study on glycated hemoglobin levels and new-onset chronic kidney disease among non-diabetic Japanese adults
Abstract Chronic kidney disease (CKD) is a major global public health problem. Recent studies reported that diabetes and prediabetes are risk factors for developing CKD; however, the exact glycated hemoglobin (HbA1c) cut-off value for prediabetes remains controversial. In this study, we aimed to exa...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-08-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-40300-8 |
_version_ | 1797452729061212160 |
---|---|
author | Yukari Okawa Etsuji Suzuki Toshiharu Mitsuhashi Toshihide Tsuda Takashi Yorifuji |
author_facet | Yukari Okawa Etsuji Suzuki Toshiharu Mitsuhashi Toshihide Tsuda Takashi Yorifuji |
author_sort | Yukari Okawa |
collection | DOAJ |
description | Abstract Chronic kidney disease (CKD) is a major global public health problem. Recent studies reported that diabetes and prediabetes are risk factors for developing CKD; however, the exact glycated hemoglobin (HbA1c) cut-off value for prediabetes remains controversial. In this study, we aimed to examine the relationship between HbA1c levels and subsequent CKD development in greater detail than previous studies. Longitudinal data of annual checkups of 7176 Japanese non-diabetic people (male: 40.4%) from 1998 to 2022 was analyzed. HbA1c values were categorized into < 5.0%, 5.0–5.4%, 5.5–5.9%, and 6.0–6.4%. CKD was defined as an estimated glomerular filtration rate < 60 ml/min/1.73 m2. The descriptive statistics at study entry showed that higher HbA1c values were associated with male, older, overweight or obese, hypertensive, or dyslipidemic people. During a mean follow-up of 7.75 person-years, 2374 participants (male: 40.0%) developed CKD. The Weibull accelerated failure time model was selected because the proportional hazards assumption was violated. The adjusted time ratios of developing CKD for HbA1c levels of 5.5–5.9% and 6.0–6.4% compared with 5.0–5.4% were 0.97 (95% confidence interval: 0.92–1.03) and 1.01 (95% confidence interval: 0.90–1.13), respectively. There was no association between HbA1c in the prediabetic range and subsequent CKD development. |
first_indexed | 2024-03-09T15:12:52Z |
format | Article |
id | doaj.art-8bc86f6b12504df58f82b72130db3d76 |
institution | Directory Open Access Journal |
issn | 2045-2322 |
language | English |
last_indexed | 2024-03-09T15:12:52Z |
publishDate | 2023-08-01 |
publisher | Nature Portfolio |
record_format | Article |
series | Scientific Reports |
spelling | doaj.art-8bc86f6b12504df58f82b72130db3d762023-11-26T13:17:12ZengNature PortfolioScientific Reports2045-23222023-08-0113111310.1038/s41598-023-40300-8A population-based longitudinal study on glycated hemoglobin levels and new-onset chronic kidney disease among non-diabetic Japanese adultsYukari Okawa0Etsuji Suzuki1Toshiharu Mitsuhashi2Toshihide Tsuda3Takashi Yorifuji4Department of Epidemiology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama UniversityDepartment of Epidemiology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama UniversityCenter for Innovative Clinical Medicine, Okayama University HospitalDepartment of Human Ecology, Graduate School of Environmental and Life Science, Okayama UniversityDepartment of Epidemiology, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama UniversityAbstract Chronic kidney disease (CKD) is a major global public health problem. Recent studies reported that diabetes and prediabetes are risk factors for developing CKD; however, the exact glycated hemoglobin (HbA1c) cut-off value for prediabetes remains controversial. In this study, we aimed to examine the relationship between HbA1c levels and subsequent CKD development in greater detail than previous studies. Longitudinal data of annual checkups of 7176 Japanese non-diabetic people (male: 40.4%) from 1998 to 2022 was analyzed. HbA1c values were categorized into < 5.0%, 5.0–5.4%, 5.5–5.9%, and 6.0–6.4%. CKD was defined as an estimated glomerular filtration rate < 60 ml/min/1.73 m2. The descriptive statistics at study entry showed that higher HbA1c values were associated with male, older, overweight or obese, hypertensive, or dyslipidemic people. During a mean follow-up of 7.75 person-years, 2374 participants (male: 40.0%) developed CKD. The Weibull accelerated failure time model was selected because the proportional hazards assumption was violated. The adjusted time ratios of developing CKD for HbA1c levels of 5.5–5.9% and 6.0–6.4% compared with 5.0–5.4% were 0.97 (95% confidence interval: 0.92–1.03) and 1.01 (95% confidence interval: 0.90–1.13), respectively. There was no association between HbA1c in the prediabetic range and subsequent CKD development.https://doi.org/10.1038/s41598-023-40300-8 |
spellingShingle | Yukari Okawa Etsuji Suzuki Toshiharu Mitsuhashi Toshihide Tsuda Takashi Yorifuji A population-based longitudinal study on glycated hemoglobin levels and new-onset chronic kidney disease among non-diabetic Japanese adults Scientific Reports |
title | A population-based longitudinal study on glycated hemoglobin levels and new-onset chronic kidney disease among non-diabetic Japanese adults |
title_full | A population-based longitudinal study on glycated hemoglobin levels and new-onset chronic kidney disease among non-diabetic Japanese adults |
title_fullStr | A population-based longitudinal study on glycated hemoglobin levels and new-onset chronic kidney disease among non-diabetic Japanese adults |
title_full_unstemmed | A population-based longitudinal study on glycated hemoglobin levels and new-onset chronic kidney disease among non-diabetic Japanese adults |
title_short | A population-based longitudinal study on glycated hemoglobin levels and new-onset chronic kidney disease among non-diabetic Japanese adults |
title_sort | population based longitudinal study on glycated hemoglobin levels and new onset chronic kidney disease among non diabetic japanese adults |
url | https://doi.org/10.1038/s41598-023-40300-8 |
work_keys_str_mv | AT yukariokawa apopulationbasedlongitudinalstudyonglycatedhemoglobinlevelsandnewonsetchronickidneydiseaseamongnondiabeticjapaneseadults AT etsujisuzuki apopulationbasedlongitudinalstudyonglycatedhemoglobinlevelsandnewonsetchronickidneydiseaseamongnondiabeticjapaneseadults AT toshiharumitsuhashi apopulationbasedlongitudinalstudyonglycatedhemoglobinlevelsandnewonsetchronickidneydiseaseamongnondiabeticjapaneseadults AT toshihidetsuda apopulationbasedlongitudinalstudyonglycatedhemoglobinlevelsandnewonsetchronickidneydiseaseamongnondiabeticjapaneseadults AT takashiyorifuji apopulationbasedlongitudinalstudyonglycatedhemoglobinlevelsandnewonsetchronickidneydiseaseamongnondiabeticjapaneseadults AT yukariokawa populationbasedlongitudinalstudyonglycatedhemoglobinlevelsandnewonsetchronickidneydiseaseamongnondiabeticjapaneseadults AT etsujisuzuki populationbasedlongitudinalstudyonglycatedhemoglobinlevelsandnewonsetchronickidneydiseaseamongnondiabeticjapaneseadults AT toshiharumitsuhashi populationbasedlongitudinalstudyonglycatedhemoglobinlevelsandnewonsetchronickidneydiseaseamongnondiabeticjapaneseadults AT toshihidetsuda populationbasedlongitudinalstudyonglycatedhemoglobinlevelsandnewonsetchronickidneydiseaseamongnondiabeticjapaneseadults AT takashiyorifuji populationbasedlongitudinalstudyonglycatedhemoglobinlevelsandnewonsetchronickidneydiseaseamongnondiabeticjapaneseadults |